https://www.zonebourse.com/cours/action/CHEMOMAB-THERAPEUTICS-LTD-120780773/actualite/Chemomab-Therapeutics-presente-a-l-EASL-2023-les-resultats-positifs-de-l-analyse-secondaire-de-so-44165314/?utm_source=telegram&utm_medium=social&utm_campaign=share